Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000222272

Medchemexpress LLC DI-82 | 1638148-50-1 | MFCD28386371 | 98.0% | 510.65 g·mol⁻¹ | C20H26N6O4S3 | 5 MG
SDP

Catalog No. 5000222272
Encompass_Preferred

DI-82 is a small-molecule inhibitor of deoxycytidine kinase (dCK) with reported biochemical potency and observed antitumor activity. It is supplied for research use in biochemical assays and preclinical studies as a powder form for laboratory workflows.

  • Potent dCK inhibition: IC50app 27.8 nM; Kiapp 9.2 nM.
  • High purity (98.0%) suitable for research applications.
  • Soluble in DMSO at 120 mg/mL; ultrasonic assistance may be needed.
  • Provided as a powder with recommended storage: -20°C for powder; -80°C for long-term storage in solvent.
  • Intended for in vitro studies and preclinical antitumor research.

Catalog No. 50-002-22272 Supplier Medchemexpress LLC Supplier No. HY1364995MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

DI-82 is a small-molecule inhibitor of deoxycytidine kinase (dCK) with reported biochemical potency and observed antitumor activity. It is supplied for research use in biochemical assays and preclinical studies as a powder form for laboratory workflows.

  • Potent dCK inhibition: IC50app 27.8 nM; Kiapp 9.2 nM.
  • High purity (98.0%) suitable for research applications.
  • Soluble in DMSO at 120 mg/mL; ultrasonic assistance may be needed.
  • Provided as a powder with recommended storage: -20°C for powder; -80°C for long-term storage in solvent.
  • Intended for in vitro studies and preclinical antitumor research.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.